The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006–2013
Open accessAbstract
OBJECTIVE: To examine temporal trends in utilization of glucose-lowering medications, glycemic control, and rate of severe hypoglycemia among patients with type 2 diabetes (T2DM). RESEARCH DESIGN AND METHODS: Using claims data from 1.66 million privately insured and Medicare Advantage patients with T2DM from 2006 to 2013, we estimated the annual 1) age- and sex-standardized proportion of patients who filled each class of agents; 2) age-, sex-, race-, and region-standardized proportion with hemoglobin A1c (HbA1c) <6%, 6 to <7%, 7 to <8%, 8 to <9%, ≥9%; and 3) age- and sex-standardized rate of severe hypoglycemia among those using medications. Proportions were calculated overall and stratified by age-group (18–44, 45–64, 65–74, and ≥75 years) and number of chronic comorbidities (zero, one, and two or more). RESULTS: From 2006 to 2013, use increased for metformin (from 47.6 to 53.5%), dipeptidyl peptidase 4 inhibitors (0.5 to 14.9%), and insulin (17.1 to 23.0%) but declined for sulfonylureas (38.8 to 30.8%) and thiazolidinediones (28.5 to 5.6%; all P < 0.001). The proportion of patients with HbA1c <7% declined (from 56.4 to 54.2%; P < 0.001) and with HbA1c ≥9% increased (9.9 to 12.2%; P < 0.001). Glycemic control varied by age and was poor among 23.3% of the youngest and 6.3% of the oldest patients in 2013. The overall rate of severe hypoglycemia remained the same (1.3 per 100 person-years; P = 0.72), declined modestly among the oldest patients (from 2.9 to 2.3; P < 0.001), and remained high among those with two or more comorbidities (3.2 to 3.5; P = 0.36). CONCLUSIONS: During the recent 8-year period, the use of glucose-lowering drugs has changed dramatically among patients with T2DM. Overall glycemic control has not improved and remains poor among nearly a quarter of the youngest patients. The overall rate of severe hypoglycemia remains largely unchanged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a population-based study of 1.66 million people filling at least 1 glucose-lowering medication prescription, the rate of severe hypoglycemia per 100 person-years was 2.3 for people 75 years and older, 1.3 for those aged 64 to 75 years, and 0.9 for younger ages.121”
From Diagnosis and Treatment of Type 2 Diabetes in Adults (2025) · cites this paper as [121]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, a meta-analysis of 7 trials of 6 injectable GLP-1RAs and 1 oral GLP-1RA among 56 004 participants with type 2 diabetes (76% with established cardiovascular disease) over a median follow-up of 1.3 to 5.4 years reported a reduction in both the primary major adverse cardiovascular events outcome (10.5% with GLP-1RA treatment vs 11.8% with placebo; hazard ratio, 0.88 [95% CI, 0.82–0.94])”
From Diagnosis and Treatment of Type 2 Diabetes in Adults (2025) · cites this paper as [108]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Self-citationEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Self-citationManagement of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Self-citationEconomic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,227
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
The National Committee for Quality Assurance
Iglehart, J. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351322 · Cited by 1,826
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 2015, Diabetes Care, 38, S1
Cited by
Sorted by citations
Items 101–200 of 306
Li, X., Qie, S., Wang, X., Zheng, Y., Liu, Y., & Liu, G. (2018) · Endocrine · doi:10.1007/s12020-018-1708-z · Cited by 23
Tan, Y. Z., Cheen, M. H. H., Goh, S., Bee, Y. M., Lim, P. S., Khee, G. Y., & Thumboo, J. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12886 · Cited by 23
Harris, S. B., Abrahamson, M. J., Ceriello, A., Charpentier, G., Evans, M., Lehmann, R., Liebl, A., Linjawi, S., Holt, R. I. G., Hosszúfalusi, N., et al. (2020) · Drugs · doi:10.1007/s40265-019-01245-3 · Cited by 21
Trends and risk factors in severe hypoglycemia among individuals with type 2 diabetes in Korea
Lee, S. E., Kim, K., Son, K. J., Song, S. O., Park, K. H., Park, S. H., & Nam, J. Y. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108946 · Cited by 22
Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan
Chu, C.-H., Hsu, C., Lin, S., Chuang, L., Liu, J., & Tu, S. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.06.001 · Cited by 20
Cao, Y., Widyahening, I. S., Sun, X., & Li, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70060 · Cited by 23
Feng, L., Lam, A. Y. R., Carmody, D., Lim, C. W., Tan, G. C. S., Goh, S., Bee, Y. M., & Jafar, T. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259157 · Cited by 18
Kårhus, M. L., Brønden, A., Sonne, D. P., Vilsbøll, T., & Knop, F. K. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12946 · Cited by 20
Nanoformulated Metformin Enhanced the Treatment of Spinal Cord Injury
Li, T., Liu, Z., Wang, J., Ye, H., Wan, Y., Du, X., Sun, X., Zhou, M., Lin, Y., Jing, P., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137227 · Cited by 18
Simplification of complex insulin therapy: a story of dogma and therapeutic resignation
Giugliano, D., Scappaticcio, L., Longo, M., Caruso, P., Maiorino, M. I., Bellastella, G., & Esposito, K. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108958 · Cited by 18
Kim, J. M., Kim, S. S., Kim, J. H., Kim, M.-K., Kim, T. N., Lee, S. H., Lee, C. W., Park, J. Y., Kim, E. S., Lee, K. J., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0274 · Cited by 17
The Risk Factors of Severe Hypoglycemia in Older Patients with Dementia and Type 2 Diabetes Mellitus
Chen, N.-C., Chen, C., & Shen, F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010067 · Cited by 17
Li, T., Jing, P., Yang, L., Wan, Y., Du, X., Wei, J. J., Zhou, M., Liu, Z., Lin, Y., & Zhong, Z. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102526 · Cited by 17
Pilla, S. J., Kraschnewski, J. L., Lehman, E. B., Kong, L., Francis, E., Poger, J. M., Bryce, C. L., Maruthur, N. M., & Yeh, H.-C. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002153 · Cited by 16
First real-world experience with bigfoot unity: a 6-month retrospective analysis
Baliga, B. S., Tillman, J. B., Olson, B., Vaughan, S., Sheikh, F. N., & Malone, J. K. (2023) · Clinical Diabetes · doi:10.2337/cd22-0126 · Cited by 15
Type 2 diabetes and treatment intensification in primary care in Finland
NISKANEN, L. K., Hahl, J., Haukka, J. K., Leppä, E., Miettinen, T. A., Mushnikov, V., Sipilä, R., Tamminen, N., Vattulainen, P., & Korhonen, P. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1199-7 · Cited by 16
Shao, H., Laxy, M., Benoit, S. R., Cheng, Y. J., Gregg, E. W., & Zhang, P. (2021) · Diabetes Care · doi:10.2337/dc20-2871 · Cited by 16
Prescription patterns and costs of antidiabetic medications in a large group of patients
Gaviria‐Mendoza, A., Sánchez‐Duque, J. A., Medina-Morales, D. A., & Machado‐Alba, J. E. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.11.002 · Cited by 18
Montvida, O., Shaw, J. E., Blonde, L., & Paul, S. K. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13288 · Cited by 15
Lam, Y. H., Leung, M. T., Ching, C. K., & Mak, T. W. L. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122020 · Cited by 16
Patoulias, D., Katsimardou, A., Kalogirou, M., Zografou, I., Toumpourleka, M., Imprialos, K. P., Stavropoulos, K., Stergiou, I., Papadopoulos, C. E., & Doumas, M. N. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.04.001 · Cited by 15
Differences in National Diabetes Treatment Patterns and Trends between Older and Younger Adults
Pilla, S. J., Segal, J. B., Alexander, G. C., Boyd, C. M., & Maruthur, N. M. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15790 · Cited by 16
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes
Watanabe, H., Du, W. J., Son, J., Sui, L., Asahara, S., Kurland, I. J., Kuo, T., Kitamoto, T., Miyachi, Y., de Cabo, R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq4126 · Cited by 16
Frazer, M., Swift, C., Gronroos, N. N., Sargent, A., Leszko, M., Buysman, E. K., Alvarez, S., Dunn, T. J., Noone, J. M., & Guevarra, M. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02677-w · Cited by 19
Handelsman, Y., Wyne, K. L., Cannon, A. J., Shannon, M. H., & Schneider, D. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.9-a.s14 · Cited by 14
Peng, X., Ayyagari, R., LUBWAMA, R. N., Shi, L., Price‐Haywood, E. G., Hollander, P. A., & Fonseca, V. A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00783-4 · Cited by 14
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
Lu, J. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00914-9 · Cited by 14
Slåtsve, K. B., Claudi, T., Lappegård, K. T., Jenum, A. K., Larsen, M., Cooper, J. G., Sandberg, S., & Berg, T. J. (2020) · Scandinavian Journal of Public Health · doi:10.1177/1403494820951004 · Cited by 15
Ambulatory noninsulin treatment of type 2 diabetes mellitus in the United States, 2015 to 2019
Heyward, J., Christopher, J., Sarkar, S., Shin, J., Kalyani, R. R., & Alexander, G. C. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14408 · Cited by 13
Hoffman, E. G., D’Souza, N. C., Liggins, R. T., & Riddell, M. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1295639 · Cited by 13
Aroda, V. R., Arulandu, J. R., & Cannon, A. J. (2018) · Clinical Diabetes · doi:10.2337/cd17-0065 · Cited by 13
Changes of glucose levels precede dementia in African‐Americans with diabetes but not in Caucasians
Hendrie, H. C., Zheng, M., Lane, K. A., Ambuehl, R. J., Purnell, C. E., Li, S., Unverzagt, F. W., Murray, M. D., Balasubramanyam, A., Callahan, C., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.03.008 · Cited by 13
The Emerging Role of Telemedicine and Mobile Health Technologies in Improving Diabetes Care
Garg, S. K., & Parkin, C. G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0090 · Cited by 14
Dhopeshwarkar, N., Brensinger, C. M., Bilker, W. B., Soprano, S. E., Flory, J., Dawwas, G. K., Gagne, J. J., Hennessy, S., & Leonard, C. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-66668-5 · Cited by 14
An automated all-in-one system for carbohydrate tracking, glucose monitoring, and insulin delivery
Huang, H., You, S. S., Tizio, L. D., Li, C., Raftery, E. M., Ehmke, C., Steiger, C., Li, J., Wentworth, A. J., Ballinger, I., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.001 · Cited by 13
Sheer, R. L., Nair, R., Pasquale, M. K., Evers, T., Cockrell, M. M., Gay, A., Singh, R., & Schmedt, N. (2022) · Journal of Primary Care & Community Health · doi:10.1177/21501319211063726 · Cited by 16
Luo, J., Gabriel, N., Korytkowski, M. T., Hernandez, I., & Gellad, W. F. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109855 · Cited by 16
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
High concurrent use of sulfonylureas and antimicrobials with drug interactions causing hypoglycemia
Pilla, S. J., Pitts, S. I., & Maruthur, N. M. (2022) · Journal of Patient Safety · doi:10.1097/pts.0000000000000739 · Cited by 12
Yang, T., Ziemba, R. E., Shehab, N., Geller, A. I., Talreja, K., Campbell, K. N., & Budnitz, D. S. (2022) · Medical Care · doi:10.1097/mlr.0000000000001682 · Cited by 12
Wan, K. S., Hairi, N. N., Mustapha, F. I., Yusof, K. M., Ali, Z. M., & Moy, F. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-86277-0 · Cited by 13
Htoo, P. T., Paik, J. M., Alt, E. M., Kim, D. H., Wexler, D. J., Kim, S. C., & Patorno, E. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad075 · Cited by 13
Koshizaka, M., Ishikawa, K., Ishikawa, T., Kobayashi, K., Takemoto, M., Horikoshi, T., Shimofusa, R., Takahashi, S., Nagashima, K., Sato, Y., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015766 · Cited by 12
Giugliano, D., Longo, M., Scappaticcio, L., Caruso, P., Gicchino, M., Petrizzo, M., Bellastella, G., Maiorino, M. I., & Esposito, K. (2023) · Endocrine · doi:10.1007/s12020-023-03547-9 · Cited by 12
Jafar, A., Pasqua, M., Olson, B., & Haidar, A. (2023) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2023.102749 · Cited by 11
Jarrar, M., Al‐Bsheish, M., Alshahri, B. K., Bamashmoos, M., Alnaimi, M. I., Alsayil, S., Basager, S., Rawashdeh, M. A., & Al-Rawashdeh, A. B. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s534066 · Cited by 13
Chen, L., Tang, Y., Huang, J., Liu, S., & Xing, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.975468 · Cited by 10
Montvida, O., Cai, X., & Paul, S. K. (2019) · Diabetes Care · doi:10.2337/dc18-1865 · Cited by 10
Lee, Y.-L., Yen, S., Shin, S., Huang, Y.-C., He, J. S., & Lin, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16050681 · Cited by 12
Runesson, B., Xu, Y., Qureshi, A. R., Lindholm, B., Barany, P. F., Elinder, C. G., & Carrero, J. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14051 · Cited by 11
Just, K. S., Tittel, S. R., Bollheimer, C., Naudorf, M., Laubner, K., Zimny, S., Zeyfang, A., Hummel, M., Stingl, J., & Holl, R. W. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.05.006 · Cited by 11
Yun, J., Han, K., & Ko, S. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13786 · Cited by 11
Tao, J., Chen, L., Chen, J., & Luo, L. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.143505 · Cited by 10
Predictive factors of hypoglycemia in type 2 diabetes: a prospective study using machine learning
Shabestari, M., Mehrabbeik, A., Barbieri, S., Marques-Vidal, P. M., Heshmati-Nasab, P., & Azizi, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-03030-7 · Cited by 14
Wang, J., Lo, S., Yeh, Y., Hwu, C., Huang, C., Hsieh, C., & Sheu, W. H. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14410 · Cited by 10
Xiang, A. S., Szwarcbard, N., Gašević, D., Earnest, A., Pease, A., Andrikopoulos, S., Wischer, N., Davis, W. A., & Zoungas, S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14506 · Cited by 10
Trends in diabetes prevalence, awareness, treatment, and control in French-speaking Switzerland
Pauli, A., de Mestral, C., & Marques-Vidal, P. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-54856-6 · Cited by 11
Hospital admissions trends for severe hypoglycemia in diabetes patients in Spain, 2005 to 2015
Orozco‐Beltrán, D., Guillen-Mollá, A., Cuenca, A. M. C., Navarro-Pérez, J., Gil-Guillén, V. F., Quesada, J. A., Pomares, F., López‐Pineda, A., & Carratalá‐Munuera, C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108565 · Cited by 10
Nguyen, J. V., Roseberry, S., Rivas, J. A., & Cauthon, K. A. B. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.112 · Cited by 10
Mata‐Cases, M., Mauricio, D., Real, J., Vlacho, B., Liébana, L. R., Molist‐Brunet, N., Cedenilla, M., & Franch‐Nadal, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175134 · Cited by 10
IDegLira for type 2 diabetes: a systematic review and meta-analysis
Liu, Y., Li, X., Zheng, Y., Wang, X., & Wang, X. (2023) · Endocrine · doi:10.1007/s12020-023-03543-z · Cited by 9
Haluzı́k, M., Taybani, Z. J., Araszkiewicz, A., Cerghizan, A., Mankovsky, B., Zuhdi, A., & Malecki, M. T. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01610-w · Cited by 10
Crowley, M. J., Gokhale, M., Pate, V., Stürmer, T., & Buse, J. B. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13589 · Cited by 9
Zhong, J., Zhang, H., Li, Z., Qian, D., Zhang, Y., Li, C., Song, Y., Qin, Z., Yu, J., Bian, S., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.947130 · Cited by 10
Nagy, D. K., Bresee, L. C., Eurich, D. T., & Simpson, S. H. (2023) · Diabetes Care · doi:10.2337/dc22-1223 · Cited by 9
Mody, R., Valentine, W. J., Hoog, M. M., Sharland, H., & Belger, M. A. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.2.153 · Cited by 11
Challenges for younger adults with diabetes.
McCoy, R. G., Kidney, R. S. M., Holznagel, D., Peters, T., & Madzura (2019) · PubMed · Cited by 9
Self-citationWan, K. S., Moy, F. M., Mustapha, F. I., Ismail, M., & Hairi, N. N. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13206 · Cited by 9
Ruan, Z., Jiang, Y., Shi, H., Jia, R., Ung, C. O. L., & Hu, H. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2174099 · Cited by 9
FURMAN, R. E., Harlan, T. S., LeBlanc, L., FURMAN, E., Liptak, G., & Fonseca, V. A. (2019) · Diabetes Care · doi:10.2337/dc19-0454 · Cited by 10
Kim, N. H., & Look, K. A. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.12.1432 · Cited by 8
Chen, Y.-L., Nguyen, P., Chien, C., Hsu, M., Liou, D.-M., & Yang, H. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111033 · Cited by 11
Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances
Liu, Z., & Yang, B. (2018) · Current Drug Targets · doi:10.2174/1389450120666181217111500 · Cited by 8
Ji, L., Wan, H., Wen, B., Wang, X., Wang, J., Bian, R., Pang, W., Tian, J., Wang, Y., Bian, F., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13967 · Cited by 8
Wang, J., Chen, H., Tang, F., & Sheu, W. H. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13485 · Cited by 8
McCoy, R. G., Lipska, K. J., Houten, H. K. V., & Shah, N. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001878 · Cited by 7
Self-citationOlaniru, O. E., & Persaud, S. J. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.07.009 · Cited by 8
Kamalinia, S., Josse, R. G., Donio, P. J., Leduc, L., Shah, B. R., & Tobe, S. W. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.100 · Cited by 7
Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients
Zhai, M. Z., Avorn, J., Liu, J., & Kesselheim, A. S. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.40117 · Cited by 7
Risk Factors for Hypoglycemia During Treatment of Hyperglycemic Crises
Ross, R. C., Vadakkel, N., Westmoreland, K., Hendrickson, A. L., Balazh, J. R., Telford, E. D., & Franck, A. J. (2022) · Diabetes Spectrum · doi:10.2337/ds21-0094 · Cited by 7
Wang, W., Guo, X., Zhang, C., Ning, T., Ma, G., Huang, Y., Jia, R., Zhou, D., Cao, M., Zhang, T., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15433 · Cited by 7
Aleksić, S., Lontchi‐Yimagou, E., Mitchell, W. G., Boyle, C., Matias, P., Manavalan, A. D., Goyal, A., Carey, M., Gabriely, I., & Hawkins, M. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae479 · Cited by 6
Direct Medical Costs Of Hypoglycemia Hospitalizations In The United States
Goyal, R., Sura, S., & Mehta, H. (2017) · Value in Health · doi:10.1016/j.jval.2017.08.562 · Cited by 7
Weng, J., Zhao, J., Zhou, Z., Guo, X., Zou, D., Ji, Q., Tong, N., Li, Q., Zhu, J., Li, Q., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12963 · Cited by 7
Overtreatment and undertreatment in a sample of elderly people with diabetes
AL‐Musawe, L., Torre, C., Guerreiro, J., Rodrigues, A. T., Raposo, J. F., Mota‐Filipe, H., & Martins, A. P. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14847 · Cited by 7
Wu, J., Yang, R., Yu, H., Qin, X., Wu, T., Wu, Y., & Hu, Y. (2023) · Nutrients · doi:10.3390/nu15143081 · Cited by 7
Zhou, C., Dong, C., Wang, Q., Fu, C., Xie, Z., Hao, W., Sun, H., & Zhu, D. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15215 · Cited by 7
Beyond basal-bolus insulin regimen: Is it still the ultimate chance for therapy in diabetes?
Giugliano, D., Bellastella, G., Maiorino, M. I., & Esposito, K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107922 · Cited by 7
Lamidi, M., Wikström, K., Inglin, L., Rautiainen, P., Tirkkonen, H., & Laatikainen, T. K. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01324-5 · Cited by 7
Bonora, B. M., Giaccari, A., Consoli, A., Broglio, F., Avogaro, A., Fadini, G. P., & for the GLIMPLES Study Investigators (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70045 · Cited by 7
Song, J., Guo, W., Jin, C., Yuan, X., Hu, X., Zhang, Z., & Lin, H. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-088318 · Cited by 6
Sagalla, N., Yancy, W. S., Edelman, D. E., Jeffreys, A. S., Coffman, C. J., Voils, C. I., Alexopoulos, A., Maciejewski, M. L., Dar, M. S., & Crowley, M. J. (2020) · Chronic Illness · doi:10.1177/1742395320968627 · Cited by 6
Betry, C., Lablanche, S., Carvalho, M., Amougay, H., Boullay, H. D., Crand, A., Lamy, C., Borges, L., Gorain, S., Borel, J., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110698 · Cited by 8
Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes
Williams, B. A., RAJPURA, J. R., Paprocki, Y., Kumar, N., Voyce, S. J., Brady, J. P., & Chang, A. R. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.07.012 · Cited by 7
Wu, R., Zhang, J., Zou, G., Li, S., Wang, J., Li, X., & Xu, J. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s450321 · Cited by 6
The American Diabetes Association in the Era of Health Care Transformation
Hill‐Briggs, F. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0071 · Cited by 7
Optimizing mHealth Technologies in Real-World Clinical Practices
Mora, P., BIGGS, W. C., & Parkin, C. G. (2019) · Clinical Diabetes · doi:10.2337/cd18-0081 · Cited by 6
Gotfredsen, D. R., VINTHER, S. M., Petersen, T. S., Cortes, R., Jensen, T. B., Jimenez‐Solem, E., & Christensen, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60818-5 · Cited by 6
Zarei, L., Peymani, P., Moradi, N., Kheirandish, M., Mirjalili, M., & Zare, M. (2020) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2020.152 · Cited by 6
Diabetes is a cardiovascular disease, isn’t it?
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.006 · Cited by 6
Metadata
- Authors
- Lipska, K. J., Yao, X., Herrin, J., McCoy, R. G., Ross, J. S., Steinman, M. A., Inzucchi, S. E., Gill, T. M., Krumholz, H. M., & Shah, N. D.
- Affiliations
- Yale University (US)
- Mayo Clinic (US)
- Yale New Haven Hospital (US)
- University of California, San Francisco (US)
- Corresponding author
- Lipska, Kasia J.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-09-22
- Volume
- 40
- Issue
- 4
- Pages
- 468-475
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5360291
- OpenAlex
- W2523617397
- Semantic Scholar
- 6b4700268ff332c2ae444b5f7bdbed9cf6cd276e
- Cited by
- 306
- References
- 44
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 22 · 2023: 40 · 2022: 34 · 2021: 37 · 2020: 44 · 2019: 40 · 2018: 44 · 2017: 26 · 2016: 1
- FWCI
- 37.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Center for Advancing Translational Sciences (UL1 TR000135)
- National Institute on Aging (K23AG048359, P30AG021342, K24AG049057, P30AG044281, K07AG3587)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, glucose-lowering medications, drug use trends, glycemic control, HbA1c, severe hypoglycemia, metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, insulin, comorbidities, Medicare Advantage
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Drug Utilization, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Retrospective Studies, Sulfonylurea Compounds, Comorbidity, Logistic Models, Thiazolidinediones, Dipeptidyl-Peptidase IV Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
